Article Sidebar
Published:
Jul 7, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Osthole represses growth of multiple myeloma cells by regulating PI3K/AKT and ERK pathways
Abstract
Purpose: To identify the effects of osthole on the growth of multiple myeloma cells and determine the probable molecular mechanism of action.
Methods: 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay was used to measure multiple myeloma cell viability. Flow cytometry was used for the evaluation of cell cycle and apoptosis. For protein expression measurement, western blot analysis was employed.
Results: The results show that osthole dose- and time-dependently suppressed the viability of multiple myeloma cells (p < 0.01). Osthole also dose-dependently initiated multiple myeloma cell cycle arrest in G0/G1 phase (p < 0.05) and induced multiple myeloma cell apoptosis (p < 0.01). Moreover, western blotting revealed a significant reduction in cyclin D1 (p < 0.01) and induction in p21, cleaved caspase 3 and cleaved poly (ADP-ribose) polymerase (p < 0.01). Furthermore, osthole treatment significantly downregulated the phosphorylation levels of protein kinase B (AKTT308), AKTS473, and extracellular regulated protein kinase 1/2 (ERK1/2).
Conclusion: These findings demonstrated that osthole inhibited viability and induced cell cycle arrest and apoptosis of multiple myeloma cells by regulating PI3K/AKT and ERK pathways. Osthole may be considered as a potential anticancer agent for the therapy of multiple myeloma.
